10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
There is good news for contractors in Utah who take care to appropriately mark, sign and warn of haz...
Read More >
On August 9, 2019, Illinois Governor J.B. Pritzker signed into law a sweeping piece of legislation, ...
Read More >
When a private equity (PE) firm acquires a closely held business, it is quite common for the seller ...
Read More >
Glenview Dealership Created Sexually Hostile Work Environment for Business Manager And Then Fired He...
Read More >
This is our Quarterly Corporate / M&A Decisions Update for decisions in Q3 2020. This update is desi...
Read More >
U.S. Citizenship and Immigration Services (USCIS) opened its initial registration period for the fis...
Read More >